Mont-Saint-Guibert, Belgium – Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the discovery and development of specialized cell therapies, today announced that Chief Executive Officer Christian Homsy will present at the 3rd Annual Regen Med Investor Day, being held Wednesday, March 25, 2015 in New York City.
Dr. Homsy will present at 10:20 a.m. ET / 3:20 p.m. CET to attending investors. During his presentation, Dr. Homsy will discuss Cardio3 BioSciences’ ongoing clinical development programs in cardiology and immuno-oncology.
Details of the Cardio3 BioSciences presentation are as follows:
- Event: ARM’s Regen Med Investor Day
- Date: March 25, 2015
- Time: 10:20 – 10:35 a.m. ET
- Location: Metropolitan Club, One East 60th Street, New York, NY 10022
At the time of the ARM Regen Med Investor Day, a live-streaming webcast of all panels and company presentations will be available at: http://www.arminvestorday.com/webcast and will be published on the event’s website shortly after the conference as well as on the company’s website in the event section: http://www.c3bs.com/en/events .
